During the past decade, Lyon - Clinique Mutualiste conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lyon - Clinique Mutualiste" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "ALK Gene Mutation" (1 trials), "BRAF Gene Mutation" (1 trials), "Colorectal Cancer" (1 trials) and "KRAS Gene Mutation" (1 trials). Many other conditions were trialed in "Lyon - Clinique Mutualiste" in a lesser frequency.

Most popular intervention types in "Lyon - Clinique Mutualiste" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Chemotherapy with platine" (1 trials), "Chemotherapy without Cisplatine" (1 trials), "FOLFIRI regimen" (1 trials), "Gammanorm" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lyon - Clinique Mutualiste" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Lyon - Clinique Mutualiste". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Lyon - Clinique Mutualiste, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lyon - Clinique Mutualiste, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".